Joerg Halter

2.1k total citations
40 papers, 742 citations indexed

About

Joerg Halter is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Joerg Halter has authored 40 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 10 papers in Public Health, Environmental and Occupational Health and 9 papers in Epidemiology. Recurrent topics in Joerg Halter's work include Hematopoietic Stem Cell Transplantation (25 papers), Acute Lymphoblastic Leukemia research (7 papers) and Acute Myeloid Leukemia Research (6 papers). Joerg Halter is often cited by papers focused on Hematopoietic Stem Cell Transplantation (25 papers), Acute Lymphoblastic Leukemia research (7 papers) and Acute Myeloid Leukemia Research (6 papers). Joerg Halter collaborates with scholars based in Switzerland, United States and France. Joerg Halter's co-authors include Jakob Passweg, Robert Peter Gale, Vikas Gupta, Philip L. McCarthy, Urs Schanz, Dominik Heim, Andreas Holbro, Stephan R. Vavricka, Sarosh R. Irani and Andreas Buser and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Joerg Halter

38 papers receiving 735 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joerg Halter Switzerland 15 483 217 150 123 111 40 742
John Doyle Canada 14 352 0.7× 222 1.0× 147 1.0× 66 0.5× 100 0.9× 27 698
Diane George United States 18 478 1.0× 148 0.7× 257 1.7× 97 0.8× 167 1.5× 47 818
Adrienne de Labarthe France 11 636 1.3× 315 1.5× 130 0.9× 158 1.3× 61 0.5× 20 831
Sabine Gerull Switzerland 17 525 1.1× 119 0.5× 218 1.5× 193 1.6× 257 2.3× 64 922
Rabi Hanna United States 14 470 1.0× 115 0.5× 188 1.3× 171 1.4× 86 0.8× 77 796
Karima Yakouben France 19 459 1.0× 265 1.2× 172 1.1× 172 1.4× 196 1.8× 50 893
Manuel Abecasis Portugal 11 488 1.0× 131 0.6× 220 1.5× 198 1.6× 230 2.1× 24 865
H Hägglund Sweden 20 564 1.2× 153 0.7× 340 2.3× 199 1.6× 213 1.9× 34 1.0k
Kerstin Schaefer‐Eckart Germany 11 468 1.0× 141 0.6× 225 1.5× 181 1.5× 100 0.9× 23 831
Sven Klaesson Sweden 15 495 1.0× 145 0.7× 134 0.9× 227 1.8× 178 1.6× 26 777

Countries citing papers authored by Joerg Halter

Since Specialization
Citations

This map shows the geographic impact of Joerg Halter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joerg Halter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joerg Halter more than expected).

Fields of papers citing papers by Joerg Halter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joerg Halter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joerg Halter. The network helps show where Joerg Halter may publish in the future.

Co-authorship network of co-authors of Joerg Halter

This figure shows the co-authorship network connecting the top 25 collaborators of Joerg Halter. A scholar is included among the top collaborators of Joerg Halter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joerg Halter. Joerg Halter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Passweg, Jakob, et al.. (2025). Busulfan Once Versus Four Times Daily: Impact on Pharmacokinetics, Organ Toxicities and Survival After Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 31(8). 571–583. 1 indexed citations
2.
Berg, J., Dominik Heim, Joerg Halter, et al.. (2024). Influence of comorbidities on outcome in 1102 patients with an allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 59(11). 1525–1533.
3.
Zhu, Jie, Alexander A. Navarini, Joerg Halter, & Simon M. Mueller. (2023). Pruritus in cutaneous graft‐versus‐host disease: A systematic review. Journal of the European Academy of Dermatology and Venereology. 37(7). 1276–1283. 2 indexed citations
4.
Khier, Sonia, Youssef Daali, Michael Medinger, et al.. (2023). Pharmacokinetic Modeling and Simulation with Pharmacogenetic Insights Support the Relevance of Therapeutic Drug Monitoring for Myeloablative Busulfan Dosing in Adult HSCT. Transplantation and Cellular Therapy. 30(3). 332.e1–332.e15. 4 indexed citations
5.
Uppugunduri, Chakradhara Rao S., Michael Medinger, Joerg Halter, et al.. (2023). Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan. Bone Marrow Transplantation. 58(7). 811–816. 5 indexed citations
6.
Tappeiner, Christoph, Arnd Heiligenhaus, Joerg Halter, et al.. (2023). Challenges and concepts in the diagnosis and management of ocular graft-versus-host disease. Frontiers in Medicine. 10. 1133381–1133381. 12 indexed citations
8.
Battegay, R, Joerg Halter, Dominik Heim, et al.. (2022). Impact of busulfan pharmacokinetics on outcome in adult patients receiving an allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. 57(6). 903–910. 16 indexed citations
9.
Vu, Diem‐Lan, Stavroula Masouridi‐Levrat, Christophe Combescure, et al.. (2020). Microbiologically documented infections after adult allogeneic hematopoietic cell transplantation: A 5‐year analysis within the Swiss Transplant Cohort study. Transplant Infectious Disease. 22(4). e13289–e13289. 12 indexed citations
10.
Drexler, Beatrice, et al.. (2020). Extracorporeal Photopheresis in Graft-versus-Host Disease. Transfusion Medicine and Hemotherapy. 47(3). 214–225. 36 indexed citations
11.
Drexler, Beatrice, Tamara Diesch, Joerg Halter, et al.. (2020). Very long-term follow-up of aplastic anemia treated with immunosuppressive therapy or allogeneic hematopoietic cell transplantation. Annals of Hematology. 99(11). 2529–2538. 17 indexed citations
12.
Goldenberger, Daniel, Sarah Tschudin‐Sutter, Joerg Halter, et al.. (2018). Diagnosis of invasive mold diseases in patients with hematological malignancies using Aspergillus, Mucorales, and panfungal PCR in BAL. Transplant Infectious Disease. 20(5). e12953–e12953. 17 indexed citations
13.
Bitan, Menachem, Suzanna M. van Walraven, Nina Worel, et al.. (2015). Determination of Eligibility in Related Pediatric Hematopoietic Cell Donors: Ethical and Clinical Considerations. Recommendations from a Working Group of the Worldwide Network for Blood and Marrow Transplantation Association. Biology of Blood and Marrow Transplantation. 22(1). 96–103. 11 indexed citations
14.
Stuehler, Claudia, Esther Kuenzli, Veronika K. Jaeger, et al.. (2015). Immune Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation and Association With Occurrence and Outcome of Invasive Aspergillosis. The Journal of Infectious Diseases. 212(6). 959–967. 50 indexed citations
15.
Jahn, Kathleen, et al.. (2013). Clinical pattern of LRTI with RSV and hMPV in immunocompromised patients. European Respiratory Journal. 42(Suppl 57). P1895–P1895. 1 indexed citations
16.
Mueller, Simon M., Alicia Rovó, Joerg Halter, et al.. (2013). Genital Chronic GVHD in Men after Hematopoietic Stem Cell Transplantation: A Single-Center Cross-Sectional Analysis of 155 Patients. Biology of Blood and Marrow Transplantation. 19(11). 1574–1580. 30 indexed citations
17.
Medinger, Michael, Martin Stern, Laura Infanti, et al.. (2012). Prospective change control analysis of transfer of platelet concentrate production from a specialized stem cell transplantation unit to a blood transfusion center. Journal of Clinical Apheresis. 27(4). 178–182. 5 indexed citations
18.
Sharon, Elad, Ánita Lawitschka, Hildegard Greinix, et al.. (2011). Metabolic bone diseases in patients after allogeneic hematopoietic stem cell transplantation: Report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease. Transplant International. 24(9). 867–879. 29 indexed citations
19.
Greinix, Hildegard, Christoph Loddenkemper, Steven Z. Pavletic, et al.. (2010). Diagnosis and Staging of Chronic Graft-versus-Host Disease in the Clinical Practice. Biology of Blood and Marrow Transplantation. 17(2). 167–175. 38 indexed citations
20.
Halter, Joerg, W.M. Michael Schuepbach, Carlo Casali, et al.. (2009). Sustained Complete Metabolic Remission After Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE).. Blood. 114(22). 1181–1181. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026